Oncolytics Biotech Inc. (ONCY) NASDAQ

1.00

+0.0084(+0.85%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap100.51M
Enterprise Value85.63M
P/E Ratio-3.99
PEG Ratio0.74
Price/Sales Ratio0
Price/Book Ratio1,222.99
Enterprise/Revenue0
Enterprise/EBITDA-3.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.34
Return On Equity-7.55

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-34.88M
Net Income-31.71M
Diluted EPS-0.41

Balance Sheet

Total Cash12.35M
Total Cash/Share0.12
Total Debt835,000
Total Debt/Equity7.26
Current Ratio1.84
Book Value Per Share0

Price History

52-Week Change23.46
52-Week High1.51
52-Week Low0.33
Moving Average 50 Days1
Moving Average 200 Days0.91

Statistics

Average Volume741,636
Shares Outstanding100.36M
% Held by Institutions3.1

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:19
Last Split DateMay 25, 2018